Radiation-induced mitotic cell death and glioblastoma radioresistance: A new regulating pathway controlled by integrin-linked kinase, hypoxia-inducible factor 1alpha and survivin in U87 cells

详细信息    查看全文

• 作者：Olivia Lanvin ; Sylvie Monferran ; Caroline Delmas ; Bettina Couderc ; Christine Toulas ; Elizabeth Cohen-Jonathan-Moyal
• 关键词：Mitotic cell death ; Centrosome duplication ; Ionising radiations ; Integrin-linked kinase ; Hypoxia-inducible factor 1alpha ; Survivin ; Glioblastoma
• 刊名：European Journal of Cancer
• 出版年：2013
• 出版时间：September, 2013
• 年：2013
• 卷：49
• 期：13
• 页码：2884-2891
• 全文大小：993 K

文摘

We have previously shown that integrin-linked kinase (ILK) regulates U87 glioblastoma cell radioresistance by modulating the main radiation-induced cell death mechanism in solid tumours, the mitotic cell death. To decipher the biological pathways involved in these mechanisms, we constructed a U87 glioblastoma cell model expressing an inducible shRNA directed against ILK (U87shILK). We then demonstrated that silencing ILK enhanced radiation-induced centrosome overduplication, leading to radiation-induced mitotic cell death. In this model, ionising radiations induce hypoxia-inducible factor 1alpha (HIF-1¦Á) stabilisation which is inhibited by silencing ILK. Moreover, silencing HIF-1¦Á in U87 cells reduced the surviving fraction after 2 Gy irradiation by increasing cell sensitivity to radiation-induced mitotic cell death and centrosome amplification. Because it is known that HIF-1¦Á controls survivin expression, we then looked at the ILK silencing effect on survivin expression. We show that survivin expression is decreased in U87shILK cells. Furthermore, treating U87 cells with the specific survivin suppressor YM155 significantly increased the percentage of giant multinucleated cells, centrosomal overduplication and thus U87 cell radiosensitivity.

In consequence, we decipher here a new pathway of glioma radioresistance via the regulation of radiation-induced centrosome duplication and therefore mitotic cell death by ILK, HIF-1¦Á and survivin. This work identifies new targets in glioblastoma with the intention of radiosensitising these highly radioresistant tumours.